メニュー
Request a Quote
お問い合わせ
JP
epigenetics-t-cell-screen-digital-white-paper1920x640
Whitepaper

Assessing the epigenetics of T cell exhaustion using CRISPR screens

A major challenge in therapeutic immuno-oncology today is the limited persistence of CAR-T cells. Many studies have focused on altering CAR structure and regulating CAR-T cell differentiation to optimize their clinical efficacy. Research is also focused on identifying new molecular targets to reduce T cell exhaustion. In this white paper, we share an interview with Dr. Verena Brucklacher-Waldert of Revvity, who discusses the epigenetics of T cell exhaustion and practical techniques to assess immune cell epigenetic regulators using CRISPS screens. For research use only. Not for use in diagnostic procedures.

A major challenge in therapeutic immuno-oncology today is the limited persistence of CAR-T cells. Many studies have focused on altering CAR structure and regulating CAR-T cell differentiation to optimize their clinical efficacy. Research is also focused on identifying new molecular targets to reduce T cell exhaustion.

In this white paper, we share an interview with Dr. Verena Brucklacher-Waldert of Revvity, who discusses the epigenetics of T cell exhaustion and practical techniques to assess immune cell epigenetic regulators using CRISPS screens.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Assessing the epigenetics of T cell exhaustion using CRISPR screens

Download Whitepaper